BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Home > article

S. Korea unveils practical goal to vaccinate 70% of population

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 21, 2020, 13:22 | Updated : August 21, 2020, 13:22
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Pohang City]


SEOUL -- South Korea will try to make a quick acquisition of COVID-19 vaccines that can inoculate at least 70 percent of its entire population through cooperation with an international body or foreign companies if the independent development of effective vaccines is dragged out.

The decision was made at an anti-epidemic conference chaired by Health and Welfare Minister Park Neung-hoo. South Korea has unveiled a roadmap for the treatment of COVID-19 to develop plasma treatment by the year's end as well as antibody treatment and vaccines next year.

"In order to protect the lives and safety of the people, the government will try to secure vaccines that can immunize the entire nation. In case of difficulty, however, vaccines will be acquired in stages so that at least 70 percent can be inoculated," Park said, adding negotiations are also under way with foreign companies.

Park said that South Korea would actively participate in COVAX Facility, an organization created to guarantee quick and equitable access to COVID-19 vaccines throughout the world. The government decided to preferentially vaccinate health officials, workers at essential social facilities, soldiers, old people and those suffering from chronic disease.

At talks on August 20 between Prime Minister Chung Sye-kyun and pharmaceutical companies involved in the development of vaccines, Celltrion Chairman Seo Jung-jin said that quick government approval would help companies expedite clinical trials. "We will step up efforts to realize regular production by the first half of next year at the latest," Seo said.

Celltrion has been involved in a state project to produce therapeutic antibodies in the first half of next year. In an evaluation test, Celltrion's antibody treatment was found to be effective in neutralizing the mutated strain of the SARS-CoV-2 coronavirus. SK Bioscience will produce the antigen of a vaccine candidate being developed by Novavax, an American vaccine development company.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Health officials heave sigh of relief at early introduction of Novavax vaccine .
    Health officials heave sigh of relief at early introduction …
  • .Syringes for COVID-19 vaccines added to list of K-quarantine technologies.
    Syringes for COVID-19 vaccines added to list of 'K-quarantin…
  • .Semiconductor-based fast test kit using saliva able to debut in March: science minister.
    Semiconductor-based fast test kit using saliva able to debut…
  • .Russias Sputnik vaccine draws attention ahead of new CMO deal in S. Korea.
    Russia's Sputnik vaccine draws attention ahead of new CMO de…
  • .Kimchi refrigerator maker develops portable ultra-low temperature freezer for vaccines.
    Kimchi refrigerator maker develops portable ultra-low temper…

Real Time Photo News

  • .Girl band (G)I-DLE shrinks size to five members after school bullying controversy.

    Girl band (G)I-DLE shrinks size to five members after school bullying controversy

  • .Singer-actress IU reveals release schedule for album LILAC.

    Singer-actress IU reveals release schedule for album 'LILAC'

  • .S. Korea to build state-run K-pop concert hall for unaffordable online performances .

    S. Korea to build state-run K-pop concert hall for unaffordable online performances

  • .BLACKPINK member Rosé to release solo album in March.

    BLACKPINK member Rosé to release solo album in March

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

Latest News

more+

  • Young woman faces trial for eating hamberger and insulting train passenger
  • Girl band (G)I-DLE shrinks size to five members after school bullying controversy
  • S. Korean companies to build combined cycle power plant in Thailand
  • Transparent LED film displays videos and images at official venue of Busan film festival
  • Daredevil surfers to be fined for ignoring storm warning
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view